High drug prices are restricting people who need access to potentially life saving medications, from getting what they need. In the U.S. when government authorized patents expire, pharmaceutical companies rush to buy the patents and raise the prices of drugs by 6,000 percent. Martin Shkreli, at a conference, said he didn’t go far enough when raising the price of HIV drug Daraprim by more than 5,000 percent. Now with the rapid growth of digital and medical technology some may have to rethink their strategies for the future.
